Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$24.39

-1 (-3.94%)

18:05
11/14/17
11/14
18:05
11/14/17
18:05

Biohaven Pharmaceutical reports Q3 EPS ($1.19), consensus ($1.10)

Reports cash as of September 30 was $175.8M. Cash as of December 31, 2016, prior to the Company's initial public offering, was $23.6M.

  • 28

    Nov

BHVN Biohaven Pharmaceutical
$24.39

-1 (-3.94%)

09/25/17
MSCO
09/25/17
NO CHANGE
Target $47
MSCO
Overweight
Biohaven price target raised to $47 from $28 at Morgan Stanley
Morgan Stanley analyst Matthew Harrison noted that Phase 2/3 data from trigriluzole in spinocerebellar ataxia, the lead program within Biohaven Pharmaceutical's glutamate platform, is expected in Q4. The analyst, who assigns a 75% chance of success, believes his previous estimates for trigriluzole in SCA were too conservative and now sees it reaching long-term share of about 50% given the lack of other therapies. He raised his price target on Biohaven to $47 from $28 and keeps an Overweigh rating on the stock.
10/02/17
NEED
10/02/17
NO CHANGE
Target $36
NEED
Strong Buy
Biohaven target lowered to $36 on failed study at Needham
Needham analyst Alan Carr lowered his price target for Biohaven Pharmaceutical to $36 from $43 after the company reported the trigriluzole Phase 2/3 trial in spinocerebellar ataxia missed the primary endpoint. The analyst removed the program from his model but continues to expect a positive Phase 3 readout for rimegepant in Q1 of 2018. Carr keeps a Buy rating on Biohaven.
10/03/17
MSCO
10/03/17
NO CHANGE
Target $38
MSCO
Overweight
Biohaven price target lowered to $38 from $47 at Morgan Stanley
Morgan Stanley analyst Matthew Harrison removed spinocerebellar ataxia from his model for Biohaven Pharmaceutical after trigriluzole did not succeed in a Phase II/III study. However, given trigriluzole was not associated with any safety issues, he did not adjust his assumptions about the probability of success for the company's other three glutamate programs. Harrison lowered his price target on Biohaven to $38 from $47, but keeps an Overweight rating on the stock, adding that he believes positive data in Q1 from its migraine trial could push the stock into "the mid-$50s."
10/03/17
NEED
10/03/17
NO CHANGE
NEED
Biohaven Pharmaceutical price target lowered to $36 from $43 at Needham
Needham analyst Alan Carr cut his price target on Biohaven after the company's trigriluzole drug missed its primary endpoint in a Phase 2/3 trial. The analyst removed the drug from his model but remains upbeat on the outlook for the Phase 3 trial of the company's trigriluzole drug, whose data is due out in 1Q18. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

WBS

Webster Financial

$65.97

0.91 (1.40%)

07:44
07/19/18
07/19
07:44
07/19/18
07:44
Earnings
Webster Financial reports Q2 EPS 92c, consensus 87c »

Reports Q2 NII $225.0M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

RDS.A

Royal Dutch Shell

$68.90

0.12 (0.17%)

07:43
07/19/18
07/19
07:43
07/19/18
07:43
Upgrade
Royal Dutch Shell rating change  »

Royal Dutch Shell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LC

LendingClub

$4.41

0.055 (1.26%)

07:40
07/19/18
07/19
07:40
07/19/18
07:40
Downgrade
LendingClub rating change  »

LendingClub downgraded as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

MS

Morgan Stanley

$50.54

1.34 (2.72%)

07:40
07/19/18
07/19
07:40
07/19/18
07:40
Recommendations
Morgan Stanley analyst commentary  »

Morgan Stanley saw strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$36.45

0.8 (2.24%)

07:39
07/19/18
07/19
07:39
07/19/18
07:39
Hot Stocks
Novocure announces 13 Tumor Treating Fields presentations at ASTRO »

Novocure announced 13…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

MSFT

Microsoft

$105.08

-0.92 (-0.87%)

07:38
07/19/18
07/19
07:38
07/19/18
07:38
Technical Analysis
Technical Earnings Preview: Microsoft near life highs before earnings »

The shares are in an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

  • 08

    Aug

  • 04

    Sep

TEX

Terex

$44.28

0.17 (0.39%)

07:37
07/19/18
07/19
07:37
07/19/18
07:37
Downgrade
Terex rating change  »

Terex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

EBAY

eBay

$37.95

0.13 (0.34%)

07:37
07/19/18
07/19
07:37
07/19/18
07:37
Downgrade
eBay rating change  »

eBay downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHCO

City Holding

$76.84

0.45 (0.59%)

07:37
07/19/18
07/19
07:37
07/19/18
07:37
Earnings
City Holding reports Q2 EPS $1.35, consensus $1.13 »

Return on assets and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

ADS

Alliance Data

$226.51

1.13 (0.50%)

07:35
07/19/18
07/19
07:35
07/19/18
07:35
Hot Stocks
Alliance Data CEO says Q2 'marked the beginning of acceleration in our business' »

Ed Heffernan, president…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

MSFT

Microsoft

$105.08

-0.92 (-0.87%)

, DIS

Disney

$110.71

0.41 (0.37%)

07:35
07/19/18
07/19
07:35
07/19/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

MSFT

Microsoft

$105.08

-0.92 (-0.87%)

DIS

Disney

$110.71

0.41 (0.37%)

CZR

Caesars

$11.50

0.05 (0.44%)

RHT

Red Hat

$148.51

0.99 (0.67%)

OMC

Omnicom

$70.59

-0.1 (-0.14%)

FTI

TechnipFMC

$30.94

0.28 (0.91%)

ETFC

E-Trade

$63.14

2 (3.27%)

HLT

Hilton

$82.92

1.86 (2.29%)

BYD

Boyd Gaming

$37.89

-0.44 (-1.15%)

MT

ArcelorMittal

$30.99

0.665 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 01

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 09

    Aug

  • 04

    Sep

AMZN

Amazon.com

$1,842.36

-1.64 (-0.09%)

, FB

Facebook

$209.35

-0.64 (-0.30%)

07:35
07/19/18
07/19
07:35
07/19/18
07:35
Recommendations
Amazon.com, Facebook, Twitter analyst commentary  »

JPMorgan continues to…

AMZN

Amazon.com

$1,842.36

-1.64 (-0.09%)

FB

Facebook

$209.35

-0.64 (-0.30%)

TWTR

Twitter

$43.34

-1.36 (-3.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 27

    Jul

  • 16

    Aug

  • 18

    Sep

ADS

Alliance Data

$226.51

1.13 (0.50%)

07:34
07/19/18
07/19
07:34
07/19/18
07:34
Earnings
Breaking Earnings news story on Alliance Data »

Alliance Data reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

DPZ

Domino's Pizza

$283.74

1.74 (0.62%)

07:33
07/19/18
07/19
07:33
07/19/18
07:33
Hot Stocks
Domino's Pizza reports Q2 domestic SSS up 6.9% »

Reports Q2 international…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 21

    Sep

  • 05

    Oct

MNK

Mallinckrodt

$21.81

0.19 (0.88%)

07:33
07/19/18
07/19
07:33
07/19/18
07:33
Recommendations
Mallinckrodt analyst commentary  »

Mallinckrodt price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 09

    Aug

  • 13

    Aug

  • 22

    Aug

STBA

S&T Bancorp

$43.96

0.19 (0.43%)

07:33
07/19/18
07/19
07:33
07/19/18
07:33
Earnings
S&T Bancorp reports Q2 EPS 61c, consensus 61c »

Reports Q2 NIM 3.64%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

ONDK

On Deck Capital

$8.09

0.6 (8.01%)

07:32
07/19/18
07/19
07:32
07/19/18
07:32
Downgrade
On Deck Capital rating change  »

Morgan Stanley sees On…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 15

    Aug

  • 16

    Aug

ADS

Alliance Data

$226.51

1.13 (0.50%)

07:32
07/19/18
07/19
07:32
07/19/18
07:32
Earnings
Breaking Earnings news story on Alliance Data »

Alliance Data backs FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

ADS

Alliance Data

$226.51

1.13 (0.50%)

07:31
07/19/18
07/19
07:31
07/19/18
07:31
Earnings
Alliance Data backs FY18 core EPS view $22.50 to $23.00, consensus $22.57 »

CEO Heffernan continued:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

DPZ

Domino's Pizza

$283.74

1.74 (0.62%)

07:31
07/19/18
07/19
07:31
07/19/18
07:31
Earnings
Domino's Pizza reports Q2 adjusted EPS $1.84, consensus $1.75 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 21

    Sep

  • 05

    Oct

ADS

Alliance Data

$226.51

1.13 (0.50%)

07:30
07/19/18
07/19
07:30
07/19/18
07:30
Earnings
Alliance Data reports Q2 core EPS $5.01, consensus $4.66 »

Reports Q2 revenue $1.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

LONE

Lonestar Resources

$10.37

0.42 (4.22%)

07:30
07/19/18
07/19
07:30
07/19/18
07:30
Initiation
Lonestar Resources initiated  »

Lonestar Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

CMCSA

Comcast

$34.03

-0.23 (-0.67%)

, FOXA

21st Century Fox

$46.69

0.22 (0.47%)

07:30
07/19/18
07/19
07:30
07/19/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

CMCSA

Comcast

$34.03

-0.23 (-0.67%)

FOXA

21st Century Fox

$46.69

0.22 (0.47%)

GM

General Motors

$39.87

-0.185 (-0.46%)

PZZA

Papa John's

$53.60

2.06 (4.00%)

HPQ

HP Inc.

$23.54

-0.06 (-0.25%)

GOGO

Gogo

$3.91

0.15 (3.99%)

MDR

McDermott

$17.97

-0.075 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 31

    Jul

SQ

Square

$68.30

-0.02 (-0.03%)

07:28
07/19/18
07/19
07:28
07/19/18
07:28
Upgrade
Square rating change  »

Square upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 15

    Aug

  • 16

    Aug

MEET

Meet Group

$4.14

0.08 (1.97%)

07:26
07/19/18
07/19
07:26
07/19/18
07:26
Upgrade
Meet Group rating change  »

Meet Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.